293 related articles for article (PubMed ID: 31726940)
41. Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway.
Yang S; Zhang X; Qu H; Qu B; Yin X; Zhao H
Cancer Gene Ther; 2020 May; 27(5):368-377. PubMed ID: 31182761
[TBL] [Abstract][Full Text] [Related]
42. PUMA inactivation protects against oxidative stress through p21/Bcl-XL inhibition of bax death.
Vitiello PF; Staversky RJ; Keng PC; O'Reilly MA
Free Radic Biol Med; 2008 Feb; 44(3):367-74. PubMed ID: 18215742
[TBL] [Abstract][Full Text] [Related]
43. Protoporphyrin IX interacts with wild-type p53 protein in vitro and induces cell death of human colon cancer cells in a p53-dependent and -independent manner.
Zawacka-Pankau J; Issaeva N; Hossain S; Pramanik A; Selivanova G; Podhajska AJ
J Biol Chem; 2007 Jan; 282(4):2466-72. PubMed ID: 17135250
[TBL] [Abstract][Full Text] [Related]
44. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas.
Bukholm IK; Nesland JM
Virchows Arch; 2000 Mar; 436(3):224-8. PubMed ID: 10782880
[TBL] [Abstract][Full Text] [Related]
45. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
[TBL] [Abstract][Full Text] [Related]
46. Harnessing the p53-PUMA axis to overcome DNA damage resistance in renal cell carcinoma.
Zhou X; Tolstov Y; Arslan A; Roth W; Grüllich C; Pahernik S; Hohenfellner M; Duensing S
Neoplasia; 2014 Dec; 16(12):1028-35. PubMed ID: 25499216
[TBL] [Abstract][Full Text] [Related]
47. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
[TBL] [Abstract][Full Text] [Related]
48. miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and -independent manner via PUMA-Bak axis.
Adlakha YK; Saini N
Cell Death Dis; 2013 Mar; 4(3):e542. PubMed ID: 23492773
[TBL] [Abstract][Full Text] [Related]
49. Mathematical model of a network of interaction between p53 and Bcl-2 during genotoxic-induced apoptosis.
Dogu Y; Díaz J
Biophys Chem; 2009 Jul; 143(1-2):44-54. PubMed ID: 19395147
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
[TBL] [Abstract][Full Text] [Related]
51. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa.
Villunger A; Michalak EM; Coultas L; Müllauer F; Böck G; Ausserlechner MJ; Adams JM; Strasser A
Science; 2003 Nov; 302(5647):1036-8. PubMed ID: 14500851
[TBL] [Abstract][Full Text] [Related]
52. JNK- and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells.
Zhao Z; Wang J; Tang J; Liu X; Zhong Q; Wang F; Hu W; Yuan Z; Nie C; Wei Y
Biochem J; 2012 Jun; 444(2):291-301. PubMed ID: 22394200
[TBL] [Abstract][Full Text] [Related]
53. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
[TBL] [Abstract][Full Text] [Related]
54. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
55. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
56. Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells.
Liu YY; Patwardhan GA; Bhinge K; Gupta V; Gu X; Jazwinski SM
Cancer Res; 2011 Mar; 71(6):2276-85. PubMed ID: 21278235
[TBL] [Abstract][Full Text] [Related]
57. Autophagic cell death induced by 5-FU in Bax or PUMA deficient human colon cancer cell.
Xiong HY; Guo XL; Bu XX; Zhang SS; Ma NN; Song JR; Hu F; Tao SF; Sun K; Li R; Wu MC; Wei LX
Cancer Lett; 2010 Feb; 288(1):68-74. PubMed ID: 19660860
[TBL] [Abstract][Full Text] [Related]
58. JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy.
Sui X; Kong N; Wang X; Fang Y; Hu X; Xu Y; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan H; Han W
Sci Rep; 2014 Apr; 4():4694. PubMed ID: 24733045
[TBL] [Abstract][Full Text] [Related]
59. Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status.
Violette S; Poulain L; Dussaulx E; Pepin D; Faussat AM; Chambaz J; Lacorte JM; Staedel C; Lesuffleur T
Int J Cancer; 2002 Apr; 98(4):498-504. PubMed ID: 11920608
[TBL] [Abstract][Full Text] [Related]
60. In vitro binding properties of tumor suppressor p53 with PUMA and NOXA.
Park SY; Jeong MS; Jang SB
Biochem Biophys Res Commun; 2012 Apr; 420(2):350-6. PubMed ID: 22446329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
